ライフサイエンスコーパス: weight increase

1 until the end of experiment as well as body weight increase.

2 termines the relative magnitude of the grain weight increase.

3 e role in determining the impact of synaptic weight increase.

4 n in the adult forebrain leads to comparable weight increase.

5 an 1,500 g (19/1,000) and decreased as birth weight increased.

6 Also, exercise capacity was reduced and lung weight increased.

7 displayed improved binding to HCAs as sample weight increased.

8 1973 to 55.4 kcal in 1994 because children's weight increased.

9 Both diets resulted in similar body weight increases.

10 k between air pollution and non-diet-induced weight increases.

11 ly increase 24EE, which rises slowly as body weight increases.

12 to long-lasting gene activation and synaptic weight increases.

13 ife was estimated without adjusting for body weight increases.

14 t along Me > Et > iPr and oligomer molecular weights increase.

15 Body weight increased 0.8 kg (CI, -0.3 to 1.8 kg) in the plac

16 In contrast, in patients receiving placebo, weight (increase, 0.1 +/- 3.1 kg), lean body mass (decre

17 Weight increased 1.4% in the SCS group and 4.3% in the M

18 ts' physicians were alerted if participants' weights increased 1.4 kg in 24 hours or 2.3 kg in 72 hou

19 s/day of jogging/running was associated with weight increase (1.57 kg, 95% confidence interval: 0.33,

20 igue (14 of 205 [6.8%] and 8 of 196 [4.1%]), weight increase (12 of 205 [5.9%] and 3 of 196 [1.5%]),

21 On average, body weight increased 25% (77 versus 100 kg) and percent body

22 t increased 1%, and the prevalence of normal weight increased 4%.

23 sing inks, provide advantages with minimized weight increase (49 mg), strong resilience against multi

24 ontrol arm displayed a significantly greater weight increase (9.54 +/- 10.21 kg) than either the EVR

25 he system (leptin resistance) for preventing weight increases above the defended value.

26 Weight increases above the obesity threshold significant

27 et (HFD) on mice, we observed increased body weight, increased adipose tissue, enlarged uterine horns

28 Age- and gender-standardized weight increased after 6 months of treatment (gross: mea

29 to the combined effects of reduced molecular weight, increased amount of hydroxyl terminal groups and

30 lin sensitivity significantly, although body weight increased and total and LDL cholesterol decreased

31 Sedation, weight increase, and hypothyroidism occurred more freque

32 Both ear thickness and weight increased (approximately 1.5-fold) in the oxazolo

33 mean 46.30 g (95% CI, 0.05 to 92.60 g) birth weight increase associated with adding financial rewards

34 Heritability for body weight increased at a rate between 0.23% and 0.57% per g

35 al features of MARC2 KO mice were lower body weight, increased body temperature, decreased levels of

36 phenotype including the persistent low birth weight, increased body weight gain in early adulthood, i

37 ice lacking Snord116 globally have low birth weight, increased body weight gain, energy expenditure a

38 which at low oral dose of 1 (mg/kg)/day body weight increased bone mass density and volume, expressio

39 Weight increase (both lean and fat mass) was greatest in

40 nate plastic, is associated with higher body weight, increased breast and prostate cancer, and altere

41 d had lower death rates than did those whose weight increased but whose serum creatinine level declin

42 Weight increased by 0.68 and 1.75 kg in the IN and RE gr

43 Relative to placebo, mean weight increased by 1.2 kg with 2 g EPA (95% CI, 0 kg to

44 Median weight increased by 1.6 kg in the insulin-glargine group

45 ear follow-up (2006-2007 to 2007-2008), mean weight increased by 1.72 kg (standard deviation, 4.3) an

46 The animals weight increased by 13.7+/-6.2% and 6.8+/-6.3% (P=0.343)

47 for 7 days, the ratio of pancreatic to body weight increased by 143%, but when rapamycin was adminis

48 of follow-up (1996-1997 to 1999-2000), mean weight increased by 2.1 kg (standard deviation (SD), 4.8

49 In the Whitehall II study, body weight increased by 2.96 +/- 6.5 kg during a follow-up o

50 GHS treatment, the ratio of LV mass to body weight increased by 44% from untreated values.

51 with the others, they found that mean birth weight increased by 50 g and 200 g with glucose concentr

52 Birth weight increased by 50.7 g and 33.6 g per SD of fGS (P =

53 Weight increased by 6.35 kg in the sugar-free group as c

54 was 25% in LPG but only 5% in FPG, and graft weight increased by 64% in LPG while remaining unchanged

55 Between 34 and 38 wk, the total kidney weight increased by 78% in the control group (P < 0.001)

56 The root : shoot ratio of fresh weight increased by 78-121% with SynCom but only 23-86%

57 artile range, 10.5-11.2 weeks) of treatment, weight increased by 8.5 kg (95% confidence interval [CI]

58 MA5 and MA7 fractions with higher molucular weight increased by a maximum of ~7- and 9-fold, respect

59 The rate of growth in height and weight increased by a mean of 85 and 131 percent, respec

60 white adipose tissue are compromised and fat weight increases by the FoxO1/ATF4 interaction.

61 hazelnut seeds) to the tomato matrix (1:1 by weight) increases CO2 diffusion through the highly dense

62 llbirths; reduced gestation length and birth weight; increased concentrations of glucose and free fat

63 dosing guidance (0.5-1 g/kg/d estimated body weight, increasing daily by 0.5-1 g/kg/d to a maximum of

64 Among the non-obese, as gVOL rose, weight increased disproportionately rapidly.

65 leted 50 weeks of therapy, the mean absolute weight increase during continuation treatment was simila

66 y, to our knowledge, providing evidence that weight increase during the first year of life is positiv

67 apacity, and decreased DOM average molecular weight (increased E2/E3 ratios).

68 The weight-increasing effect of fructose in hypercaloric tri

69 8l-ko and Nat8l-ako mice showed reduced body weight, increased energy expenditure, and improved gluco

70 t malabsorption evidenced by increased fecal weight, increased fecal fats, and the presence of undige

71 Irinotecan dose-dependently reduced body weight, increased fecal water content and increased gast

72 d circulating lymphocytes, spleen and thymus weights, increased free fatty acids (FFA) and produced h

73 Body weight increased from 32.16 +/- 2.34 g to 43.03 +/- 1.44

74 mm and second MVR 22+/-3 mm, and their body weight increased from 7.4+/-2.8 kg to 16.8+/-10.5 kg.

75 nt ingested 2 g/meal natural bile acids, her weight increased from 80 to 98 lb, without side effects.

76 c pulmonary compliance corrected for patient weight increased from a median of 0.16 mL/cm H2O per kil

77 pulmonary compliance (normalized for patient weight) increased from 0.12 +/- 0.02 to 0.28 +/- 0.08 mL

78 ry cholesterol absorbed (mg/d per 100 g body weight) increased from 1.2 +/- 0.2 to 14.7 +/- 4.4 in th

79 lues ([activity/g]/[injected activity/g body weight]) increased from 0.72 +/- 0.06 (mean +/- SEM; n =

80 anned cesarean delivery, maternal postpartum weight increase >10 kg, maternal postpartum metabolic sy

81 For the highest quartile, low birth weight increased >5-fold, fetal growth restriction incre

82 ude decreased growth (both linear growth and weight), increased illness (usually diarrhea), interacti

83 A 1-SD weight increase in childhood was associated with a 1.6%

84 t and increased liver weight account for the weight increase in EP3R(-/-) mice.

85 g (SFRS8)] was associated with the degree of weight increase in response to extra energy intake.SFA o

86 st that baseline DNA methylation can predict weight increase in response to overfeeding in humans.

87 used a lower threshold to define postpartum weight increase in the composite outcome (>5 kg compared

88 relative risk 0.4 for 1 mL/kg predicted body weight increase in tidal volume, 95% confidence interval

89 trials, the volume increased as the object's weight increased in an effort to assist with trunk stabi

90 oratory subgroup analysis of soy group data, weight increased in subjects producing equol but not in

91 Body weight increased in the sucrose group and decreased in t

92 Although ventricular weight increased in wild-type mice, the increase was gre

93 tic factor associated with clozapine-induced weight increases in schizophrenia.

94 d decreased survival and higher loss of body weight, increased intestinal bleeding, higher apoptosis

95 e animals have larger tumors, decreased body weight, increased lactate dehydrogenase production, and

96 Excess weight increases morbidity risk after colorectal cancer

97 Weight increased more than 2.0% during mobilization in 5

98 nsgenic mice, but heart and left ventricular weights increased more in littermates than in FVB.Igf+/-

99 observed beyond this time) led to lower body weights, increased mucosal inflammation, increased colon

100 g tolvaptan groups, respectively, and a body weight increase of +0.32+/-0.46 kg in the placebo group

101 Participants who switched to TAF had a mean weight increase of +0.5 kg at 144 weeks over those who m

102 rent deamidation only results in a molecular weight increase of 1 Da.

103 A birth weight increase of 1 kg was associated with a 44% greate

104 ng sample preparation results in a molecular weight increase of 3 Da due to the incorporation of the

105 e weight-based rule-of-thumb algorithms (eg, weight increase of 3 lbs in 1 day or 5 lbs in 7 days) th

106 Mean weight increases of 2.2 kg. and 0.9 kg occurred in the r

107 the population attributable risk was 27% for weight increases of 5 kg or more.

108 and 0.21 (95% CI [0.14, 0.28]; p < 0.001) kg weight increase, of which 76.5% (95% CI [61.9; 91.1]) wa

109 ravascular lung water indexed for ideal body weight increased only in cases with weaning-induced pulm

110 Female mice did not show any significant weight increase or associated metabolic defects.

111 stimated total effect on adult SBP of a 1-SD weight increase over the mean throughout the first decad

112 f the amount of MVPA at any time point, body weight increased over time.

113 s of life (13.2% [5.4-20.9] change per 100 g weight increase; p=0.001) independent of birthweight, ge

114 pups, more late fetal deaths, reduced fetal weight, increased placental weight and reduced fetal:pla

115 F48 rats had reduced body weight, increased plasma beta-hydroxybutyrate, and reduc

116 liver, because diet had no effect on uterine weight increases produced by EE.

117 race-sex group also experienced significant weight increases related to aging during their early to

118 In contrast, larval weights increased relative to the controls when Heliothi

119 d neonatal animals displayed increased liver weights, increased serum aspartate aminotransferase (AST

120 Participants' weight increased sharply at Christmas/New Year (mean [SE

121 Body weight increased significantly by 2.6 kg (P<.001) in men

122 The mean (+/-SD) weight increased significantly during the holiday period

123 However, the mean body weight increased significantly with PGA and 3/10 became

124 e given one injection of BHT (200 mg/kg body weight) increased significantly (P < 0.01) as compared t

125 sing first-MVR weight-matched controls, body weight increased similarly for patients <2 years old who

126 arity, hydrophilicity, and average molecular weight increased slightly (10.3%).

127 in females, but it remains unknown when the weight increase starts.

128 d adverse events, with the most common being weight increase (ten [8%]) and neutropenia (five [4%]).

129 on-based twin cohort revealed that low birth weight increased the risk for development of IBS, with e

130 Excess body weight increases the risk of death from any cause and fr

131 y biological materials) either increases the weight, increases the thickness, or reduces reflectivity

132 DNA species obtained are higher in molecular weight, increasing the chances of detection of different

133 Increasing T2 weighting increased the negative enhancement effect and

134 Larger molecular weight increased their porosity (=decreased cross-link d

135 When adjusting for recipient weight, increasing time from LT to ECMO initiation was a

136 eatures of GI GVHD, including decreased body weight, increased tissue inflammation, and lymphocytic i

137 before CFPD, during which time average body weight increased to 63%+/-22% above admission body weigh

138 hypertrophy (ratio of ventricular mass/body weight increased to 7.6+/-0.3 mg/g in wild-type mice com

139 ons in an engram join together with synaptic weight increases to support facilitated recall of memori

140 th the hypothesis and imply that gross brain weight increase towards humans required change in only o

141 yed, and after-dinner energy intake and body weight increased versus baseline.

142 The mean weight increase was 5.5 kg; half was attributable to dev

143 n occurred in 67% of patients and the median weight increase was 7.3%.

144 At one year, after two OGLDs, weight increase was less with basal compared with pre-mi

145 Weight increase was not related to initial body mass ind

146 Besides, the molecular weight increase was similar for amylose and amylopectin

147 formance, measured as population increase or weight increase, was negatively related to GS levels, bu

148 pite an order of magnitude variation in body weight; increased weight is supported solely through dis

149 cues: visual weights decrease and vestibular weights increase when visual stimuli are degraded.

150 Underreporting of weight increased with age, and underreporting of height

151 Egg weight increased with female length, as expected, but th

152 he amount of phospholipid expressed as % dry weight increases with increasing u(max) in microalgae.

153 eight with monomer conversion: the molecular weights increase with increasing monomer conversion, exh

154 Mean daily wet and dry stool weights increased with each fiber addition.

155 semi-logarithmic kinetic plots and molecular weights increasing with conversion were observed.

156 Mean birth weight increases within families ranged from 33 g (black